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Correlative light and electron microscopy 
suggests that mutant huntingtin dysregulates 
the endolysosomal pathway in presymptomatic 
Huntington’s disease
Ya Zhou1, Thomas R. Peskett2,3, Christian Landles1, John B. Warner4, Kirupa Sathasivam1, Edward J. Smith1, 
Shu Chen2, Ronald Wetzel5, Hilal A. Lashuel4, Gillian P. Bates1*†  and Helen R. Saibil2† 
Abstract 
Huntington’s disease (HD) is a late onset, inherited neurodegenerative disorder for which early pathogenic events 
remain poorly understood. Here we show that mutant exon 1 HTT proteins are recruited to a subset of cytoplasmic 
aggregates in the cell bodies of neurons in brain sections from presymptomatic HD, but not wild-type, mice. This 
occurred in a disease stage and polyglutamine-length dependent manner. We successfully adapted a high-resolution 
correlative light and electron microscopy methodology, originally developed for mammalian and yeast cells, to allow 
us to correlate light microscopy and electron microscopy images on the same brain section within an accuracy of 
100 nm. Using this approach, we identified these recruitment sites as single membrane bound, vesicle-rich endolyso-
somal organelles, specifically as (1) multivesicular bodies (MVBs), or amphisomes and (2) autolysosomes or residual 
bodies. The organelles were often found in close-proximity to phagophore-like structures. Immunogold labeling 
localized mutant HTT to non-fibrillar, electron lucent structures within the lumen of these organelles. In presympto-
matic HD, the recruitment organelles were predominantly MVBs/amphisomes, whereas in late-stage HD, there were 
more autolysosomes or residual bodies. Electron tomograms indicated the fusion of small vesicles with the vacuole 
within the lumen, suggesting that MVBs develop into residual bodies. We found that markers of MVB-related exocy-
tosis were depleted in presymptomatic mice and throughout the disease course. This suggests that endolysosomal 
homeostasis has moved away from exocytosis toward lysosome fusion and degradation, in response to the need to 
clear the chronically aggregating mutant HTT protein, and that this occurs at an early stage in HD pathogenesis.
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Introduction
Huntington’s disease (HD) is a late onset, inherited neu-
rodegenerative disorder that manifests with psychiatric 
disturbances, movement disorders and cognitive decline 
[4]. It is caused by a CAG repeat expansion in exon 1 of 
the huntingtin gene (HTT) that encodes an abnormally 
long polyglutamine (polyQ) tract in the huntingtin pro-
tein (HTT) [26]. Individuals with CAG expansions of 
35 or less remain unaffected, those with 40 or more will 
develop HD within a normal lifespan, and 36-39 CAGs 
confer an increasing risk of developing the disease [63]. 
CAG expansions of approximately 65 or more can result 
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in onset during childhood or adolescence [72]. Hunting-
tin aggregates are deposited in the brains of HD patients 
in the form of inclusions that are predominantly cyto-
plasmic and scattered throughout the neuropil in cell 
bodies, dendrites and axons [12, 19]. They also occur as 
nuclear inclusions, the frequency of which increases with 
increasing CAG repeat length [12]. Neuronal cell death 
occurs in the striatum, cortex and other brain regions 
[51, 76].
The propensity for mutant HTT to aggregate is gov-
erned by the extent of the polyQ expansion, and the 
length of the N-terminal HTT fragment in which it 
resides [68]. The exon 1 HTT protein is particularly 
aggregation-prone [68]. An incomplete splicing event 
that occurs in knockin mouse models of HD, as well as 
patient brains and cell lines, results in a small polyade-
nylated transcript that encodes this highly pathogenic 
protein [52, 67]. In addition to this, N-terminal frag-
ments of mutant HTT are generated by the proteolysis of 
full-length HTT [17, 30, 37, 79]. Exon 1 HTT self-assem-
bles in  vitro to form insoluble end-stage amyloid-based 
fibrillar aggregates with a cross-β-sheet architecture [65, 
69]. The initiating exon 1 HTT associations are thought 
to occur through α-helix-rich interactions of the first 
17 amino acids (N17), leading initially to spherical, 
α-helix rich oligomeric structures [27, 58, 73]. This may 
enhance the elongation of a stochastically-formed polyQ 
β-hairpin, facilitating nucleation of a β-sheet-based amy-
loid structural motif [22, 80] to which additional exon 1 
HTT monomers are recruited [77]. Our recent descrip-
tion of a liquid to solid phase transition for exon 1 HTT 
proteins indicates that the mutant HTT aggregation 
process in cells may involve liquid-like assemblies prior 
to the formation of fibrillar structures or other stable 
aggregates [57]. Regardless of the specific steps preced-
ing nucleation, post-nucleation amyloid growth appears 
to proceed via oligomeric nanofibrils that possess key 
functional attributes of amyloid substructure: the ability 
to grow into mature fibrils by recruitment of monomeric 
exon 1 HTT [13, 80].
HTT inclusions have been shown to have a fibril-
lar sub-structure in  vivo and cryo-electron tomography 
of exon 1 HTT inclusions in cell models also revealed a 
fibrillar structure that distorted the organization of the 
endoplasmic reticulum (ER) and perturbed ER mem-
brane dynamics [5, 62, 68]. Inclusions in  vivo are com-
plex structures which sequester many other proteins 
[25] and may perturb multiple processes critical to cel-
lular function. Cell culture experiments previously sug-
gested that the formation of inclusions might be part of a 
homeostatic protective mechanism [2]. However, subse-
quent experiments suggest that inclusions can be directly 
cytotoxic [45]. A recent study showed that an aggregated 
form of exon 1 HTT, possessing a fundamental amy-
loid substructure, was the toxic species of mutant HTT 
in HD flies and transfected neurons, although the exact 
nature of this amyloid species, i.e. an inclusion, dispersed 
fibril cluster, or nanofibril, was not determined [13, 80]. 
The use of a seeding assay has demonstrated that minute 
quantities of small self-propagating exon 1 HTT fibrils 
were sufficient to dramatically shorten the lifespan of HD 
transgenic flies [3].
It was previously shown that a subset of cytoplasmic 
inclusion bodies in tissue sections from HD mouse mod-
els and HD patient post-mortem brains, termed “aggrega-
tion foci”, were competent to recruit polyQ peptides [53]. 
Here, we set out to determine the ultrastructure of these 
recruitment foci, which appeared indistinguishable from 
nuclear and other cytoplasmic inclusions by anti-HTT 
antibody staining. We found that fluorescently labelled 
exon 1 HTT proteins were recruited to sites within neu-
ronal cell bodies, in brain sections from two distinct 
HD mouse models, in a polyQ-length and disease-stage 
dependent manner. In order to identify the structures 
of these recruitment foci, we established a correlative 
light and electron microscopy (CLEM) procedure to co-
locate fluorescent signals with EM images on the same 
brain section. We found that the exon 1 HTT proteins 
were recruited to single membrane-bound, vesicle-rich 
organelles that resembled multivesicular bodies (MVBs) 
or amphisomes, whereas others, with single or multi-
ple vacuoles, resembled autolysosomes or residual bod-
ies. Immunogold labelling localized the mutant HTT to 
non-fibrillar, electron-lucent regions within the lumen 
of these organelles. Our finding that markers of MVB-
related exocytosis were depleted in presymptomatic HD 
mice provides further evidence to indicate that endolys-




All procedures were performed in accordance with 
the Animals (Scientific Procedures) Act 1986 and were 
approved by the University College London Ethical 
Review Process Committee. zQ175 knock-in mice were 
generated by replacing exon 1 of mouse Htt with exon 
1 from human HTT, carrying a highly expanded CAG 
repeat [21, 50] from which the neo selectable marker has 
been removed (delta neo) [16] and were bred by back-
crossing zQ175 males to C57BL/6  J females (Charles 
River). R6/2 mice are transgenic for the 5′ region of the 
mutant human huntingtin (HTT) gene [48] and were 
bred by crossing R6/2 males to C57BL/6JOlaHsd x 
CBA/CaOlaHsd F1 females (B6CBAF1/OlaHsd, Envigo, 
Netherlands).
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Within each colony, genetically modified and wild-type 
mice were group housed with up to five mice per cage, 
dependent on gender, but genotypes were mixed. Mice 
were housed in individually ventilated cages with Aspen 
Chips 4 Premium bedding (Datesand) with environ-
mental enrichment which included chew sticks and play 
tunnel (Datesand). They had unrestricted access to food 
(Teklad global 18% protein diet, Envigo) and water. The 
temperature was regulated at 21  °C ± 1  °C and animals 
were kept on a 12  h light/dark cycle. The animal facil-
ity was barrier-maintained and quarterly non-sacrificial 
FELASA screens found no evidence of pathogens. For 
molecular analyses, mice were sacrificed by a schedule 
1 procedure, brains were rapidly dissected, tissues were 
snap frozen in liquid nitrogen and stored at − 80 °C.
Genotyping and CAG repeat sizing
Genotyping and CAG repeat sizing were performed by 
PCR of ear-biopsy DNA and all primers were from Inv-
itrogen. For zQ175 mice, a 20 μL genotyping reaction 
contained 10—15  ng DNA, GoTaq Flexi buffer, 2.5  mM 
 MgCl2, 0.2  mM dNTPs, 1.0  μM 19Fhum [5′-AGG AGC 
CGC TGC ACCGA-3′], 1.0 μM 431R2 [5′-CTC TTC ACA 
ACA GTC ATG TGCG-3′] and 1.0 U GoTaq2 polymer-
ase (Promega). Cycling conditions were 30 s at 98 °C, 34 
x (15  s at 98  °C, 15  s at 64  °C, 30  s at 72  °C), 5  min at 
72 °C. The amplified products were 324 bp for wild-type 
and 240  bp for zQ175. For R6/2 mice, a 10 μL reaction 
contained 50—100 ng DNA, 1.0 μM forward primer [5′-
CGC AGG CTA GGG CTG TCA ATC ATG CT-3′], 1.0  μM 
reverse primer [5′-TCA TCA GCT TTT CCA GGG TCG 
CCA T-3′], 1.0  μM forward internal control primer [5′-
AGC CCT ACA CTA GTG TGT GTT ACA CA-3′], 1.0  μM 
reverse internal control primer [5′-CTT GTT GAG AAC 
AAA CTC CTG CAG CT-3′] and Dream Taq Hot Start 
Green PCR Master Mix (Thermo Fisher Scientific). 
Cycling conditions were 3  min at 95  °C, 34 × (30  s at 
95 °C, 30 s at 60 °C, 1 min at 72 °C), 15 min at 72 °C.
For CAG repeat sizing for both zQ175 and R6/2, a 25 
μL reaction contained 25–50  ng DNA, 0.2  μM FAM-
labelled forward primer [5′-CCT TCG AGT CCC TCA 
AGT CCTT-3′], 0.2  μM reverse primer [5′-CGG CTG 
AGG CAG CAG CGG CTGT-3′], AmpliTaq Gold 360 
Master Mix (Thermo Fisher Scientific) and GC enhancer 
(Thermo Fisher Scientific). Cycling conditions were 
10  min at 95  °C, 34 × (30  s at 95  °C, 30  s at 63  °C and 
90  s at 72  °C), 7  min at 72  °C. Samples were run on an 
ABI3730XL Genetic Analyser with MapMarker ROX 
1000 (Bioventures) internal size standards and analyzed 
using GeneMapper v5 software (Thermo Fisher Scien-
tific). The mean CAG repeat size for all zQ175 mice was 
191.7 ± 4.6 (S.D.) and for R6/2 was 182.1 ± 1.8 (SD).
Recruitment assay with biotinylated peptides
The recruitment of the mbPEGQ30 peptide and sub-
sequent immunohistochemistry was performed as 
described in [53] with modifications. In brief, mice were 
perfused and 30  μm free-floating brain sections pre-
pared as described previously [36]. Sections were washed 
in phosphate buffered saline (PBS) and treated with 1% 
sodium borohydride in PBS for 30  min. Borohydride 
was removed by washing three times in PBS. Sections 
were permeabilized and blocked by washing three times 
in PBS with 0.3% triton (PBST) and incubated overnight 
with 10 nM mbPEGQ30 in PBST at 4 °C. Rigorous wash-
ing was performed to remove unbound peptides with 
PBST over several hours at room temperature. Sections 
were then washed three times in PBS before signal ampli-
fication using Elite ABC reagent (Vector). Sections were 
washed three times in TI buffer (0.05  M Tris pH 7.4, 
0.05  M Imidazole (Sigma) in PBS). Signals were ampli-
fied using the Tyramide Signal Amplification kit (Perkin 
Elmer) according to the manufacturer’s recommenda-
tions. The sections were then mounted on glass slides 
and processed through 70%, 90% and 100% alcohols 
and xylene before cover-slipping with DPX mountant 
(Sigma). Histological images were obtained using a Zeiss 
AxioSkop2 plus microscope fitted with a Zeiss AxioCam 
HRc colour camera. Images were recorded using Zeiss 
AxioVision 4.7.
Recruitment assay with fluorescent proteins 
and immunofluorescence
Free-floating brain sections were prepared as above. Sec-
tions were permeabilized in 0.3% PBST and washed three 
times in PBS. Sections were treated with TrueBlack (Cat 
No. 23007, Biotium) according to the manufacturer’s 
recommendations to quench autofluorescence. Control 
sections were always included to check for complete 
autofluorescence quenching. Sections were then incu-
bated with exon1 HTT peptides at 50  nM in PBS over-
night at 4  °C. Rigorous washing in 12 or 24 well plates 
four to six times of an excess of PBS was performed for 
6 to 8 h at room temperature or for 24–48 h at 4 °C. For 
immunofluorescence, sections were incubated with pri-
mary antibodies (Additional File 1: Table S1) overnight at 
4  °C. Sections were washed and incubated with second-
ary antibodies (all at 1:1000, Thermo Fisher Scientific) for 
1  h at room temperature or overnight at 4  °C. Sections 
were counterstained with Hoechst and mounted for con-
focal microscopy.
Confocal microscopy and image analysis
Confocal imaging and analysis were performed as previ-
ously described with modifications [84]. In brief, images 
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were recorded on a Zeiss LSM710 confocal microscope 
by collecting random fields within hippocampal CA1, 
cortical or striatal regions. Imaging settings were kept 
consistent for wild-type and HD sections in each experi-
ment. Sample autofluorescence levels were routinely 
checked by using additional imaging channels. Images 
were analysed with Fiji (RRID: SCR_002285) and Icy 
(Version 2.2.3.0; https:// icy. bioim agean alysis. org; RRID: 
SCR_010587) software. Pearson correlation coefficients 
(PCCs) were calculated in Fiji using the JACoP plugin 
[6]. To determine whether S830 labelling was enriched 
at the exon 1 HTT recruitment sites, these regions were 
identified by thresholding in the HTT-exon1-43Q chan-
nel, then squares centred on the HTT-exon1-43Q signal 
were randomly cropped, using only the HTT-exon1-43Q 
channel to guide cropping. If the cropped regions hap-
pened to contain large nuclear aggregates, visible in the 
S830 channel during downstream analysis, they were 
discarded. PCCs were then calculated using HTT-exon1-
43Q and S830 channels in the cropped regions. As a neg-
ative control, pixels in the S830 channel were randomly 
shuffled using a custom python (https:// www. python. 
org/) script and the PCCs were re-calculated. The same 
method was used to assess enrichment of LAMP1 at the 
exon1 HTT recruitment sites. The brightness and con-
trast were adjusted only for presentation purposes.
Correlative light and electron microscopy (CLEM)
CLEM was performed as described in [1, 33] with modi-
fications. Mice were perfused with 4% paraformaldehyde 
(PFA), brains removed and immediately sectioned into 
100 μm slices on a vibratome (Leica Microsystems), then 
incubated with fluorescently labelled HTT-exon1-43Q 
in 1  M phosphate buffer at 4  °C. Tissue sections were 
high-pressure frozen in 100 μm-deep wells of aluminium 
carriers in the presence of 20% bovine serum albumin 
(BSA, Sigma) using a HPM100 (Leica Microsystems). 
Freeze substitution and Lowicryl HM20 (Polysciences, 
Inc.) resin embedding were performed as previously 
described [57], and 0.008% uranyl acetate in acetone 
was used for freeze substitution. Sections of 70–300 nm 
thickness were cut with an Ultra 35° diamond knife (Dia-
tome) on an ultramicrotome (Leica Microsystems). The 
sections were picked up with 200 mesh gold NH2 finder 
grids coated with holey QUANTIFOIL carbon film (hole 
size = 3.5  μm separated by 1  μm). For high-accuracy 
CLEM, 50  nm fluorescent TetraSpeck beads (custom 
order, Thermo Fisher Scientific) were adsorbed onto the 
grids for fluorescence light microscopy as described [1]. 
For electron tomography, 10 nm gold particles (Electron 
Microscopy Sciences) were adsorbed onto both sides of 
the sections. A Tecnai F20 transmission electron micro-
scope (TEM) (equipped with a Direct Electron DE-20 
detector operated at 200  kV) or FEI Polara F30 TEM 
(fitted with a Quantum energy filter (Gatan) operated in 
zero-loss imaging mode with a 20 eV energy-selecting slit 
at 300 kV and a K2 Summit direct electron detector) were 
used to generate low magnification whole grid maps and 
intermediate magnification montage maps by Navigator 
using SerialEM [49, 70]. QUANTIFOIL carbon film holes 
and sample landmarks recognizable in both LM and EM 
were used for the initial correlation. Further fiducial-
based correlation was done using the ec-CLEM plugin in 
Icy as described [56].
Immunogold labelling
Immunogold labelling was performed as described in 
[23] with modifications. Ultrathin sections were pre-
pared on QUANTIFOIL finder grids and fluorescence 
recorded as described above. Grids were incubated in 
0.05 M glycine in Tris-buffered saline (TBS, pH 7.6) for 
20  min and then incubated in blocking buffer (5% BSA 
and 0.1% cold water fish skin gelatine in TBS) for 15 min. 
After two 5 min washes in blocking buffer, the grids were 
transferred to incubation buffer (1% BSA and 0.1% cold 
water fish skin gelatine in TBS) containing anti-HTT 
antibodies (S830 or mEM48, both at 1:20) and incubated 
for 48–72 h at 4 °C in a humidified chamber. After three 
washes in the incubation buffer, the grids were incubated 
with secondary antibodies conjugated to 10 nm or 20 nm 
gold (ab39609 or ab27242, Abcam, at 1:50 dilution) for 
1  h at room temperature. Grids washed three times in 
TBS and post-fixed in TBS containing 2% glutaraldehyde 
(Sigma) for 5 min. The grids were rinsed three times in 
distilled water and post-stained for TEM.
Electron tomography data collection and processing
Electron tomograms were collected using a FEI Tec-
nai T12 as previously described [57] or a FEI Tecnai G2 
Polara operating at 300 kV and equipped with Quantum 
energy filter (Gatan) operated in zero-loss imaging mode 
with a 20  eV energy-selecting slit. Data were recorded 
on a K2 Summit direct electron detector (Gatan) operat-
ing in counting mode at dose rate 5.974  e− per pixel per 
second with a final sampling of 4.41  Å per pixel. Defo-
cus ranged between − 3.5 and − 6 µm. The dose-symmet-
ric tilt scheme [20] implemented in SerialEM [49] was 
used to collect tilt series between − 60° and 60°, with 3° 
increments and a total exposure of 600–700  e−/Å2. 60 
frames were collected per tilt and aligned with Motion-
Cor2 version 1.0.5 [83]. Tomograms were reconstructed 
from tilt series by weighted back-projection using the 
IMOD package, version 4.9 [32]. Tomography data have 
been deposited in the Electron Microscopy Data Bank 
(EMDB).
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Western blotting
Western blotting was performed as previously described 
[36]. Briefly, mouse hippocampal samples were homog-
enized in ice-cold IGEPAL RIPA buffer with protease 
inhibitors at 4 °C. 20 or 40 µg of total protein in Laemmli 
loading buffer was denatured at 85  °C for 10  min and 
separated by 7.5-, 10-, or 12% Criterion TGX Stain-free 
SDS-PAGE (Bio-Rad) and blotted onto 0.45  µm nitro-
cellulose membrane (Bio-Rad) by submerged transfer 
apparatus (Bio-Rad). Membranes were then blocked and 
incubated overnight with gentle agitation at 4 °C with the 
primary antibody (Additional File 1: Table  S1). Protein 
was detected by chemiluminescence (Clarity, Bio-Rad) 
according to the manufacturer’s instructions and signals 
were captured on a ChemiDoc Touch MP Imaging Sys-
tem (Bio-Rad).
Quantification and statistical analysis
Statistical analyses were performed by Student’s t-test, 
one-way or two-way ANOVA with Šidák post-hoc cor-
rection in GraphPad Prism (Version 8) or Welch’s t-test 
in R (https:// www.r- proje ct. org/). p < 0.05 considered sta-
tistically significant; n represents animals or biological 
replicates. Where shown, ns = not significant, *p < 0.05, 
**p < 0.01, ***p < 0.001. For all graphs, the bars show 
mean values, while the error bars represent the standard 
deviation (SD).
Results
Mutant exon 1 HTT proteins are recruited to a subset 
of the cytoplasmic inclusions in HD mouse brains
It had been demonstrated previously that synthetic, 
biotinylated polyQ peptides were recruited to aggrega-
tion foci in tissue sections from HD post-mortem brain 
and HD mouse models, but not to brain sections from 
control subjects or wild-type mice [53]. To investigate 
this phenomenon further, we began by testing whether 
one of these peptides, 30 glutamines conjugated to bio-
tin via a polyethylene glycol linker (mbPEGQ30), might 
be recruited to aggregates in brain sections from the 
zQ175 knockin mouse model of HD. We detected aggre-
gates capable of polyQ peptide recruitment throughout 
the brain of heterozygous zQ175 mice (Fig.  1a). These 
recruitment foci did not necessarily co-localize with 
the HTT inclusions detected by anti-HTT antibodies 
(Fig.  1b), consistent with the previous report [53]. The 
S830 anti-HTT antibody identified HTT aggregates in 
the form of small inclusion bodies in the nucleus and 
cytoplasm (Fig. 1b, blue arrowheads) as well as a diffuse 
granular stain that filled neuronal nuclei (Fig.  1b, pur-
ple arrows). In contrast, the mbPEGQ30 peptide was 
recruited to structures that appeared as defined puncta 
(Fig. 1b, black arrows), and these recruitment foci could 
be detected in the cortex and hippocampal CA1 region as 
early as three months of age.
To investigate the nature of the recruitment foci, we set 
out to determine whether these structures could recruit a 
fluorescently labelled exon 1 HTT protein. Exon 1 HTT, 
with a polyQ stretch of 43 glutamines (HTT-exon1-43Q), 
was synthesized as previously described [75, 78], and 
conjugated at the C-terminus with either an Alexa Fluor 
488 (AF488) or Alexa Fluor 647 (AF647) dye. The fluo-
rescently labelled exon 1 HTT proteins were applied to 
brain sections from zQ175 mice at 6 months of age and 
from R6/2 mice at 12  weeks of age, together with their 
respective wild-type littermate controls. At these ages, 
the zQ175 mice are presymptomatic and yet to present 
overt behavioral phenotypes [21, 50], with end-stage dis-
ease not occurring until approximately 20 months of age. 
However, R6/2 mice are symptomatic, having developed 
pronounced motor and cognitive impairments before 
8 weeks of age [44, 60]. HTT-exon1-43Q was recruited to 
structures distributed throughout the brain sections for 
both zQ175 and R6/2 mice (Fig.  2a, b). The fluorescent 
signal was not quenched by either pre- or post-treatment 
with Trueblack (Additional File 1: Fig. S1), indicating that 
it did not represent autofluorescence. Next, we immuno-
probed HTT-exon1-43Q treated sections with the S830 
anti-HTT antibody and examined them for evidence of 
colocalization in the cortex, striatum and hippocam-
pus. S830 detects nuclear aggregation in the form of a 
diffuse granular pattern as well as nuclear inclusions; it 
also labels cytoplasmic aggregates in the form of inclu-
sion bodies that are perinuclear or scattered through-
out the neuropil [10, 40] (Fig.  2a, b). Colocalization of 
HTT-exon1-43Q with S830 fluorescent signals was con-
fined to perinuclear inclusions in both zQ175 and R6/2 
mice (Fig. 2c). S830 was consistently enriched at exon 1 
HTT recruitment sites (zQ175: PCC = 0.328 ± 0.048; 
R6/2: PCC = 0.478 ± 0.074). The colocalization was 
lost when pixels in the S830 channel were shuffled 
(zQ175 shuffled: PCC =  − 0.002 ± 0.006; R6/2 shuffled: 
PCC = 0.006 ± 0.012) (Additional File 1: Fig. S2a, b).
Recruitment of the exon 1 HTT proteins to HD mouse 
brain sections was both disease‑stage and polyQ‑length 
dependent
To determine whether the extent of HTT-exon1-43Q 
recruitment to brain sections was dependent on dis-
ease progression, we applied HTT-exon1-43Q to 
coronal sections from R6/2 mice and their wild-type 
counterparts at 4, 8 and 12 weeks of age. The recruit-
ment signal was prominent on sections from both 
8- and 12-week-old mice (Fig.  3a). Although barely 
detectable by eye (Fig.  3a), quantification revealed a 
significant increase in the fluorescence intensity of 
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Fig. 1 Comparison of mbPEGQ30 peptide recruitment and S830 antibody staining on brain sections from zQ175 mice and their wild-type 
littermates. a Coronal-hemispheres from 5-month-old zQ175 mice and their wild-type littermates, either treated with the mbPEGQ30 peptide or 
immunolabelled with the S830 antibody (2.5 ×). b Zoomed-in view of cortical, striatal and hippocampal (CA1) regions from 5-month-old zQ175 
and wild-type mice, either treated with the mbPEGQ30 peptide or immunolabelled with S830. Black arrows in b point to the defined puncta of 
the recruitment signal. Purple arrows indicate the diffuse nuclear aggregation; blue arrowheads point to small inclusion bodies. WT = wild-type. 
Scale bars: a 400 μm; b 10 μm
Fig. 2 Co-localization of HTT-exon1-43Q signal with S830 antibody immunostaining. a HTT-exon1-43Q (green) was applied to TrueBlack treated 
zQ175 and wild-type brain sections from 6-month-old mice which were immunoprobed with the S830 antibody (magenta) and nuclei were 
counterstained with Hoechst (blue). HTT-exon1-43Q was recruited to perinuclear inclusions in the striatum, cortex, and hippocampus (CA1). b R6/2 
and wild-type brain sections from 12-week-old mice treated with the HTT-exon1-43Q protein were immunoprobed with S830 and nuclei were 
counterstained with Hoechst. HTT-exon1-43Q was recruited to perinuclear inclusions as shown in the hippocampal CA1 region. c Enlarged areas 
from white boxed regions in a and b, respectively. The intensity profiles were plotted along the white dotted lines. The HTT-exon-43Q protein was 
not recruited to nuclear inclusions. Scale bars: 10 μm. WT = wild-type
(See figure on next page.)
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HTT-exon1-43Q treated sections from R6/2 as com-
pared to wild-type mice at 4 weeks of age (Fig. 3c). The 
recruitment foci intensities significantly increased in 
R6/2 mice with disease progression (Fig. 3c) and HTT-
exon1-43Q was not recruited to sections from wild-
type mice at any of these ages (Fig. 3a, c).
To investigate which structural domains within exon 
1 HTT might be important for the HTT-exon1-43Q 
recruitment, we generated exon 1 HTT monomers 
with a range of polyQ lengths (15Q, 23Q, 43Q) and the 
HTT-exon1-43Q peptide lacking the first 17 amino 
acids (ΔN17-exon1-43Q). The first 17 amino acids 
of HTT are known to oligomerize through α-helix-
rich interactions [27, 73] and the polyQ tracts inter-
act though β-strand structures [22]. These proteins 
were applied to coronal sections from zQ175 mice at 
6  months and R6/2 mice at 12  weeks of age, respec-
tively. Treatment of the zQ175 brain sections with 
HTT-exon1-15Q gave a comparable signal to the wild-
type controls (Fig. 3b, d), and therefore 15 glutamines 
were not sufficient for recruitment on 6-month-old 
zQ175 brain sections. Whilst some AF488 signal was 
obtained with the HTT-exon 1-23Q peptide on zQ175 
sections, the fluorescence intensities were not sig-
nificantly increased over HTT-exon1-15Q (Fig.  3b, 
d). Treatment of the zQ175 brain sections with either 
HTT-exon1-43Q or ΔN17-exon1-43Q resulted in sig-
nificantly increased fluorescence intensities compared 
to HTT-exon1-15Q and HTT-exon1-23Q (Fig.  3b, d). 
In contrast to 6-month-old zQ175 mice, both HTT-
exon1-15Q and HTT-exon1-23Q were recruited to 
R6/2 sections from 12-week-old mice (Fig. 3b, e). The 
extent of recruitment was comparable for the HTT-
exon1-43Q and ΔN17-43Q proteins (Fig.  3b) on both 
zQ175 (Fig. 3d) and R6/2 (Fig. 3e) sections. Therefore, 
the recruitment of exon 1 HTT proteins increased 
with disease progression and aggregate burden, and 
this interaction occurred through the polyQ tract.
HTT‑exon1‑43Q proteins are recruited to single membrane 
bound, vesicle‑rich organelles
We next established a protocol for correlative light and 
electron microscopy (CLEM) to determine the ultras-
tructure of the recruitment foci. Coronal sections were 
prepared from zQ175 mice at 6 months of age, immedi-
ately after perfusion. The HTT-exon1-43Q-AF647 pep-
tide was applied to the zQ175 sections, which were then 
subjected to high-pressure freezing and freeze substitu-
tion, and the recruitment sites in the hippocampal CA1 
region were imaged. We found that the HTT-exon1-
43Q-AF647 fluorescence signal was well-preserved fol-
lowing these procedures (Fig.  4a, c, magenta), and the 
autofluorescence of the CA1 region was negligible as 
shown by auto-exposure of the sample in the 488  nm 
channel (Fig.  4b). Ultrathin sections were collected on 
QUANTIFOIL finder EM grids and fluorescence light 
microscopy (LM) images were recorded (Fig.  4e). As 
shown in Fig.  4g, the recruitment sites were identified 
as single membrane bound, vesicle rich organelles (see 
Additional File 1: Fig. S3 for larger view of the organelle 
and Additional File 2: Video S1, for tomogram). In this 
example, the recruitment organelle (magenta) was adja-
cent to a double membrane, phagophore-like structure, 
as shown in the 3D segmentation from the tomogram 
(Fig. 4h, cyan).
We used fluorescent fiducials to provide markers in the 
field of view to accurately map fluorescence to electron 
micrographs, achieving an accuracy of less than 100 nm 
[1, 33]. TetraSpeck beads have a wide fluorescence spec-
trum and can be identified in both fluorescence channels 
(Fig. 4i, green and magenta) [1]. The same sets of beads 
could be observed by both LM and EM as indicated by 
orange arrows in Fig. 4i-k. Whereas the beads were vis-
ible in multiple channels by LM, the recruitment signal 
was only seen in one channel (Fig. 4i, magenta), making it 
readily identifiable.
Tomography and 3D segmentation revealed that on 
this R6/2 section, HTT-exon1-43Q was again recruited 
to a single membrane bound, vesicle-rich structure 
containing a large vacuole (Fig. 4k, l). The organelle was 
close to a double membrane structure, either part of 
(See figure on next page.)
Fig. 3 Recruitment of exon 1 HTT proteins to brain sections from HD mouse models is disease-stage and polyQ-length dependent. a 
Representative confocal microscopy images for recruitment of HTT-exon1-43Q to the hippocampus (CA1) of R6/2 and wild-type mice at 4, 8 and 
12 weeks of age. Nuclei were counterstained with Hoechst. b Recruitment of HTT-exon1-15Q, HTT-exon1-23Q and HTT-exon1-43Q, as well as 
HTT-exon1-43Q with an N-terminal 17 amino acid truncation (ΔN17-exon1-43Q) to 6-month-old zQ175, and 12-week-old R6/2, brain sections. 
Nuclei were counterstained with Hoechst. c Quantification of fluorescence intensities of HTT-exon1-43Q treatment for R6/2 and wild-type mice 
at 4, 8 and 12 weeks of age. d, e Quantifications of fluorescence intensities of d zQ175 and e R6/2 sections treated with exon 1 HTT proteins with 
different polyQ lengths. The fluorescence intensities were normalized to the wild-type control. Statistical analysis was by two-way ANOVA. Data 
represented by mean ± S.D., two sets of 15–25 images for three replicates per experiment. *p < 0.05; **p < 0.01; ***p < 0.001, ns = not significant. 
Scale bars: 20 μm. WT = wild-type
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Fig. 4 CLEM reveals that the exon 1 HTT proteins are recruited to single membrane bound organelles. a–d 6-month-old zQ175 coronal sections 
were treated with the HTT-exon1-43Q-AF647 protein and subjected to high pressure freezing and freeze substitution. a–c Fluorescence images 
were taken at 10 × magnification using settings for a Alexa Fluor 647 showing the HTT-exon1-43Q-AF647 signal in magenta and b Alexa Fluor 488 
to show autofluorescence levels. c Merged image from a and b. d DIC at 10 × magnification. e–h Ultrathin sections were subsequently prepared 
and placed on holey carbon QUANTIFOIL EM finder grids. e LM image including both fluorescence and DIC. f White boxed area in e showing the 
overlay of the fluorescent signal with EM. g 2D EM image from the white box in f. h The corresponding tomogram section of g with segmentation 
of the tomogram shown in Additional File 2: Video S1. The recruitment signal (magenta) labelled a single membrane bound, vesicle rich organelle, 
next to a double membrane, phagophore-like structure (cyan). i–k CLEM of HTT-exon1-43Q on 12-week-old R6/2 sections with TetraSpeck beads. 
i LM image of an ultrathin brain section on a QUANTIFOIL grid with 50 nm TetraSpeck beads (shown as green puncta and indicated by orange 
arrowheads). j White-boxed area in i showing the overlay of fluorescent signal with EM. Orange arrowheads indicate the TetraSpeck beads. k 
EM image of the structure in the white boxed area in j. l the tomogram of the structure in k was used to generate this 3D segmentation. The 
recruitment signal (magenta) uncovered a single membrane-bound vesicle-rich organelle containing a large vacuole. This was adjacent to a double 
membrane structure (cyan). Solid white boxed insert is a side view of the dashed white box area. Scale bars: a = 100 μm, e = 5 μm, f = 300 nm, 
g = 200 nm, i = 5 μm, j = 450 nm, k = 200 nm. DIC = differential interference contrast, LM = light microscopy, CLEM = correlative light and electron 
microscopy, EM = electron microscopy, 3Dseg = 3D segmentation
(See figure on next page.)
Fig. 5 Mutant HTT is localized to the electron-lucent areas within the lumen of the organelles. a–f Immunogold-labelled S830 and mEM48 
antibodies were imaged on EM sections from 12-week-old R6/2 mice a, c–f shows organelles labelled with S830 10 nm gold and b with EM48 
20 nm gold. d, f Enlarged views of the boxed areas in c and e, respectively, showing that the gold particles are localized to electron-lucent areas 
inside the organelles. g Percentage of organelles that contained gold particles after immunogold labelling. Three independent experiments were 
performed for S830 and two for mEM48, with approximately 15 micrographs being imaged for each experiment. h Relative numbers of gold 
particles inside the recruitment foci compared to those in the background areas of the same QUANTIFOIL carbon hole. Statistical analysis was by 
Student’s t-test. Data represented by mean ± S.D. **p < 0.01; ***p < 0.001. Scale bars: 100 nm. -1°Ab = without primary antibody
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the endoplasmic reticulum (ER) or, once again, phago-
phore-like. Tomography and segmentation established 
that the organelle was in close-proximity to, but not in 
direct contact with, this double membrane structure 
(bottom right insert in Fig.  4l). These CLEM results 
demonstrated that the HTT-exon1-43Q proteins were 
recruited to similar, single membrane bound, vesicle-
rich organelles in both zQ175 and R6/2 mice.
Mutant HTT is localized to the lumen of the recruitment 
organelles
In order to determine which structures within the 
recruitment organelles contain mutant HTT, we used 
immunogold labelling on R6/2 brain sections from 
12-week-old mice. We first identified the recruitment 
foci by CLEM and then examined the immunogold label-
ling in those foci. Two anti-HTT antibodies were used: 
S830, labelled with 10  nm, and mEM48 labelled with 
20 nm gold particles, respectively. Both S830 (Fig. 5a, c-f ) 
and mEM48 (Fig.  5b) labelled mutant HTT within the 
recruitment foci (single membrane-bound organelles). 
In both cases, the gold particles were located in the 
lumen, especially in the electron lucent regions (Fig. 5d, 
f ), but were absent from the large vacuoles (Fig.  5b, e). 
Three independent experiments revealed that, on aver-
age, the lumen of 93% of organelles examined contained 
S830 gold particles (in total 45 out of 47 recruitment foci) 
(Fig.  5g). The mEM48 labelling was sparser, with 61% 
of the organelles containing gold particles (Fig. 5g). The 
immunogold staining background was relatively clean 
for both S830 and mEM48, with very few gold particles 
identified in the background [on the QUANTIFOIL car-
bon hole (hole size = 3.5 μm in diameter) containing the 
recruitment foci of interest] (Fig.  5h). Although fibrillar 
material is well preserved in high pressure frozen, freeze-
substituted samples, no fibrils were observed in the 
recruitment organelles.
The single‑membrane organelles differ 
between presymptomatic and late‑stage HD
Our CLEM investigations revealed similar recruitment 
organelle structures for the zQ175 knockin and R6/2 
transgenic mouse models of HD. In both cases, they 
were single membrane-bound organelles, often contain-
ing vesicles. Those with many intraluminal vesicles (ILVs) 
resembled multivesicular bodies (MVBs) or amphisomes 
(Fig. 6a, b, e and Additional File 3: Video S2) [9, 11, 15, 66, 
81]. Others, with prominent electron lucent vacuole(s), 
sometimes contained internal membranous structures 
(luminal lamellae), and resembled lysosomal organelles 
such as autolysosomes or residual bodies (Fig. 6c, d, f–h, 
Additional File 4: Video S3, and Additional File 5: Video 
S4) [7, 31, 34, 39]. Detailed analysis revealed that in zQ175 
mice, on average, 71% of the recruitment organelles were 
MVBs/amphisomes while 29% were autolysosomes/
residual bodies. In R6/2 mice, the number of MVBs/
amphisomes was on average 38%, and the number of 
autolysosome/residual bodies was 62% (Fig. 6i).
Luminal lamellae were observed in some recruitment 
organelles in both zQ175 (Fig. 6c and Additional File 4: 
Video S3) and R6/2 (Fig. 6g, h) mice. In zQ175, only 6% of 
organelles (4 out of 71) had lamellar structures, whereas 
in R6/2, this number was 26% (28 out of 106) (Fig.  6j). 
Double membrane, phagophore-like structures were fre-
quently observed in close-proximity to the recruitment 
organelles. In zQ175 mice, 34% (24 out of 71) of the orga-
nelles had an adjacent double membrane structure and in 
R6/2 mice, this was 28% (30 out of 106) (Fig. 6k).
Sequential sections through the 3D volumes of recon-
structed tomograms suggest that vesicles fuse to form 
larger vacuoles within the recruitment organelles (Fig. 6l, 
m, Additional File 4: Video S3 and Additional File 5: 
Video S4).
The recruitment organelles are members 
of the endolysosomal pathway
We next confirmed by confocal fluorescence microscopy 
that the recruitment organelles identified by CLEM were 
a subset of endolysosomal organelles. HTT-exon1-43Q 
proteins were applied to brain sections from 6-month-
old zQ175 mice, which were then immunoprobed for the 
lysosomal-associated membrane protein 1 (LAMP1), a 
marker which labels MVBs through to lysosomal orga-
nelles [8], and the anti-HTT antibody, S830. As indicated 
by white arrowheads (Fig.  7a–d), and intensity profiles 
(Fig.  7e, f ), the HTT-exon1-43Q recruitment signal 
Fig. 6 Ultrastructural analysis in zQ175 and R6/2 mice. a–h Representative recruitment foci in 6-month-old zQ175 and 12-week-old R6/2 mice. 
i Quantification of the number of MVB and autolysosome/residual bodies in zQ175 and R6/2 sections. j Quantification of the ratio between the 
number of recruitment foci with intraluminal lamellar structures and the total recruitment foci. k Quantification of the number of recruitment 
foci with phagophore-like double membrane structures as a ratio of the total number of recruitment foci. Four independent experiments with a 
total of 71 and 106 foci examined on TEM images for zQ175 and R6/2, respectively. Statistical analysis was two-way ANOVA, data represented by 
mean ± S.D. ***p < 0.001. l, m Serially displayed sections of two tomograms from c and d, presented as sequences taken as every 10th slice through 
the 8 × binned reconstructed tomograms. Related tomograms are shown in Additional File 4: Video S3 and Additional File 5: Video S4. Scale bars: 
200 nm
(See figure on next page.)
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colocalized with a subset of puncta that were LAMP1 
and S830 positive. For the recruitment signal and LAMP1 
colocalization, an enrichment of LAMP1 at the recruit-
ment sites was found (PCC = 0.483 ± 0.027), which was 
lost when the pixels in the LAMP1 channel were shuf-
fled (PCC = 0.002 ± 0.004) (Additional File 1: Fig. S2c). 
LAMP1 was also found to reside in numerous subcellu-
lar locations that were negative for the recruitment signal 
(Fig. 7b, e, f ). Therefore, the HTT-exon1-43Q protein was 
recruited to a subset of LAMP1 positive endolysosomal 
organelles.
Dysregulation of endolysosomal markers 
in presymptomatic and late‑Stage HD
We next examined whether the endolysosomal sys-
tem had been altered by measuring total protein lev-
els of endolysosomal markers that recognize early 
endosomes through to autolysosomes in zQ175 and 
R6/2 mice and their wide-type littermates. Anti-
bodies to RAB5 (early endosome), RAB7 and M6PR 
(MVB/late endosome), RAB 11 (recycling endosomes), 
RAB27 and CD63 (exosomes), LAMP1 (MVBs to 
autolysosomes) and cathepsin B and cathepsin D (lyso-
somal proteases) were used to probe western blots of 
hippocampal lysates from R6/2 mice and their wild-
type littermates at 4, 8 and 12  weeks of age (Addi-
tional File 1: Fig. S4). Reductions in LAMP1, RAB7, 
RAB27 and CD63, and an increase in cathepsin B were 
identified in R6/2 as compared to wild-type lysates 
(Additional File 1: Fig. S4). LAMP1, RAB7, RAB27, 
CD63 and cathepsin B antibodies were then used to 
determine whether these proteins were altered in hip-
pocampal lysates from zQ175 mice at 6 months of age, 
and the western blots of hippocampal lysates from 
8- and 12-week-old R6/2 mice were repeated with 
a larger number of samples. We found that levels of 
Fig. 7 The recruitment organelles are members of a dysregulated endolysosomal system. a–e Confocal images of the CA1 region from 
6-month-old zQ175 mice showing that HTT-exon1-43Q was recruited to organelles that were also immunostained with an antibody to LAMP1 and 
with S830. White arrowheads in a–d indicate the same three regions across different channels. e Merged image of all channels from a–d. The three 
dotted lines run through the puncta indicated by the arrowheads. f Intensity profiles showing the signal along the dotted lines (from left to right) in 
e. Scale bars: 10 μm
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RAB27 and CD63, both involved in MVB related exo-
cytosis [24, 54, 82], were reduced in the 6-month-old 
zQ175 and 8- and 12-week-old R6/2 lysates (Fig.  8). 
Cathepsin B was increased in the 8- and 12-week R6/2 
lysates, but not in those from zQ175 mice at 6 months 
of age (Fig. 8). To conclude, our data suggest that the 
endolysosomal system is dysregulated in HD and that 
this occurs at an early, presymptomatic stage.
Discussion
Precise CLEM targeting of pathological mutant HTT 
deposits in mouse models of HD has revealed a struc-
ture and cellular pathway that were entirely unpredicted 
by previous in vitro and cell models of HTT aggregation. 
We show that a subset of cytoplasmic antibody-detected 
‘inclusions’ in the brains of HD mouse models are sin-
gle membrane-bound, vesicle-rich organelles. These 
predominantly resemble MVBs or amphisomes in pre-
symptomatic mice and are more likely to resemble autol-
ysosomes or residual bodies at later stages of the disease 
course. Immunogold labelling localized mutant HTT to 
Fig. 8 Western blots of endolysosomal proteins in the zQ175 and R6/2 hippocampus. a Representative western blots of total protein hippocampal 
lysates from 6-month-old zQ175 mice and their wild-type littermates immunoprobed for LAMP1, RAB7, RAB27, CD63 or Cathepsin B (Cath-B). 
ATP5B served as loading control. b Quantification of the blot shown in a. c Western blots of total protein hippocampal lysates from 8-week-old 
R6/2 mice and their wild-type littermates immunoprobed for the same proteins as in a. d Quantification of the blot shown in c. e Western blotting 
of total protein hippocampal lysates from 12-week-old R6/2 mice and their wild-type littermates immunoprobed for the same proteins as in a. 
f Quantification of the blot shown in e. Statistical analysis was by Student’s t-test. n = 10 / genotype / age. The uncropped blots are shown in 
Additional File 1: Fig. S6-S8. Data represented by mean ± S.D. *p < 0.05; **p < 0.01; ***p < 0.001. Cath-B = Cathepsin B, WT = wild-type
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non-fibrillar, electron-lucent regions within the lumen of 
these organelles. We discovered that proteins important 
for exosome function were depleted in presymptomatic 
mice providing further evidence that the endolysosomal 
system is dysregulated in HD.
In this study, we set out to uncover the structures in tis-
sue sections from mouse models of HD to which polyQ 
peptides are recruited. To facilitate the potential applica-
tion of CLEM we tested the use of exon 1 HTT proteins 
chemically conjugated with fluorescent tags. We utilized 
two complementary mouse models: R6/2 mice that are 
transgenic for a human exon 1 HTT [48] and the zQ175 
knockin HD mouse model [50] with comparable mean 
CAG repeat expansions of 182 and 192 CAGs, respec-
tively. R6/2 mice progress to end-stage disease by around 
14  weeks, whereas disease progression in zQ175 mice 
is more protracted, with end-stage disease occurring at 
approximately 20 months of age. We studied the zQ175 
mice at 6 months of age prior to symptom onset and ana-
lyzed R6/2 mice over their disease course up to 12 weeks, 
allowing us to study late-stage disease in the absence of 
confounds due to ageing. Overall, we demonstrated that 
recruitment of the HTT-exon1-43Q protein occurred 
through the polyQ tract, in an N17 independent man-
ner, and increased with disease progression. We showed 
that in all cases, exon 1 HTT proteins with 15Q, 23Q 
and 43Q polyQ repeat lengths were recruited to sections 
from 12 week-old R6/2 mice, consistent with the ability 
of aggregates, once amyloid growth has been nucleated, 
to bind proteins containing polyQ tracts whether or not 
the polyQ is in the HD pathogenic range [28].
At the resolution of confocal microscopy, antibody 
staining identifies inclusion bodies in neuronal nuclei 
and throughout the neuropil in the brains of HD 
mouse models and HD patients [10, 12, 19, 40]. On the 
nanoscale, nuclear inclusions are compact, membrane-
less fibril-containing assemblies [10, 74]. Consistent 
with the recruitment of the biotinylated polyQ pep-
tide [53], we found that the HTT-exon1-43Q peptide 
was not recruited to nuclear inclusions, but instead, 
to a subset of cytoplasmic sites in the cell body. Struc-
tures of polyQ containing aggregates have previously 
been identified by CLEM in yeast cells, immortalized 
cell lines and primary mouse neurons that overexpress 
an expanded polyQ, showing that the deposition of 
aggregates depends greatly on the cellular environment 
and context [5, 18, 57, 62]. Application of correlative 
microscopy to tissue sections is much more challeng-
ing. Previously, it has been used to uncover the struc-
ture of Lewy bodies in Parkinson’s disease post-mortem 
brain sections, by correlating LM and EM images on 
adjacent sections, revealing vesicle-rich, mainly non 
Fig. 9 Schematic depiction of endolysosomal pathway dysregulation in Huntington’s disease. a The endolysosomal pathway under normal 
conditions. Early endosomes mature into multivesicular bodies (MVBs) containing many intraluminal vesicles (ILVs). MVBs can either merge with 
the plasma membrane to release ILVs as exosomes or undergo lysosomal degradation. Macroautophagy (autophagy) starts with the formation of 
a phagophore to engulf cellular contents. Expansion and maturation of the phagophore gives rise to the double-membraned autophagosome. 
Autophagosomes can either fuse with lysosomes to form an autolysosome or can merge with MVBs to form an amphisome. Amphisomes are 
believed to either undergo exocytosis or fuse with lysosomes. Eventually, MVBs, autophagosomes and amphisomes fuse with lysosomes and their 
contents are degraded and recycled. b In HD, it is likely that HTT aggregates are engulfed by a phagophore into an autophagosome and then 
enter amphisomes through the fusion of MVBs and autophagosomes to form this hybrid organelle. Alternatively, aggregates could be taken up by 
MVBs. Organelles over-loaded with HTT aggregates may become dysfunctional and/or be targeted for further autophagy and degradation. In this 
process, exocytosis through MVBs and amphisomes could be reduced and lysosomal or autophagic dysfunction may occur. This would result in the 
accumulation of MVBs/amphisomes and autolysosome/residual bodies containing HTT aggregates that was observed in HD brain sections
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fibrillar aggregates [71]. Unfortunately, this method 
was not applicable for our study due to the challenge of 
fluorescent labelling after osmium tetroxide treatment 
and the smaller size of the recruitment foci. Instead, we 
successfully adapted a high-precision CLEM methodol-
ogy originally developed for mammalian and yeast cells 
[1, 33]. This allowed us to correlate LM and EM on the 
same mouse brain sections at an accuracy of < 100 nm, 
consistent with the cell-based studies [1, 33].
Our CLEM analysis revealed that these recruitment 
foci were single membrane-bound, vesicle-rich struc-
tures. Those with many intraluminal vesicles (ILVs) 
resembled MVBs or amphisomes [9, 11, 15, 66, 81] and 
others, containing vacuole(s) and in some cases internal 
membranous structures (luminal lamellae), resembled 
autolysosomes or residual bodies [7, 31, 34, 39]. The pres-
ence of luminal lamellae has been associated with vari-
ous lysosomal storage diseases [11, 35]. Here we found 
more organelles containing luminal lamellae in late-stage 
HD, possibly due to the accumulation of cellular lipids in 
lysosomes as a result of lysosomal dysfunction. However, 
we cannot exclude the possibility that some of the mem-
branous structures came directly from the cellular orga-
nelles/debris engulfed by autophagy. Therefore, the exact 
mechanism of lamellae formation, and how it relates to 
HD, requires further investigation. The proportions of 
MVB-like structures and autolysosomes in zQ175 and 
R6/2 brains at 6  months and 12  weeks of age, respec-
tively, suggested that the MVBs/amphisomes transition 
to autolysosomes/residual bodies during disease pro-
gression. In support of this, examination of membrane 
contacts in the 3D reconstructions provided evidence of 
vesicle fusion to form the large vacuole within the autol-
ysosomes. Double membrane phagophore-like struc-
tures were frequently observed in close-proximity to the 
recruitment organelles in both zQ175 and R6/2 mice, an 
association that might be underestimated. TEM images 
of the sections were used to estimate the number of cases 
in which phagophore-like double membranes were asso-
ciated with the organelles. Since some associated phago-
phore-like structures might lie outside the plane of the 
section, the true number of associations could be greater. 
On the other hand, we cannot exclude the possibility that 
some of these double membranes are smooth ER. Future 
studies with large volume 3D EM reconstruction will be 
valuable in further clarifying this association.
The endolysosomal pathway links exosome biogenesis 
and autophagy and is important in responding to stress 
and maintaining homeostasis in health and disease [14, 
81] (Fig.  9). Early endosomes mature into MVBs which 
are late endocytic compartments containing many ILVs. 
MVBs can fuse with the plasma membrane, releas-
ing the intraluminal vesicles into the extracellular space 
as exosomes. Through the process of macroautophagy, 
cytoplasmic proteins and organelles are engulfed by the 
double membraned phagophore to form autophago-
somes, which fuse with lysosomes to degrade the con-
tents. Alternatively, autophagosomes can fuse with MVBs 
to form hybrid organelles termed amphisomes, which are 
thought to eventually fuse with lysosomes. Amphisomes 
can also fuse with the plasma membrane and secrete 
their contents (Fig. 9a).
We demonstrated by immunogold antibody labelling 
that mutant HTT is localized within the recruitment 
organelles, in electron lucent areas. Whilst no discernible 
fibrils or other structures were detected, the presence of 
small aggregates, well under 10  nm in diameter, cannot 
be excluded, and such nanostructures could act as polyQ 
recruitment centres. Why would aggregated HTT within 
the organelles recruit the exon 1 proteins, when fibrillar 
aggregates present at other locations in the cell, e.g. the 
nucleus, do not? It is possible that the acidic environ-
ment of these organelles has rendered aggregated HTT 
competent for HTT-exon1-43Q recruitment, possibly 
by stripping extraneous, non-specifically bound compo-
nents from the growing end, or by inducing a more disor-
dered state in which the polyQ region is more accessible 
to the label. The aggregated HTT present in the orga-
nelles may have entered the endolysosomal pathway via 
autophagy, through the fusion of autophagosomes with 
MVBs to form amphisomes. Aggregated HTT may have 
been incorporated into the lumen of MVBs/endosomes, 
as occasionally, we observed immunogold HTT associ-
ated with small vesicular structures next to the recruit-
ment organelles, an observation that requires further 
investigation (Fig.  9b). Alternatively, exogenous exon 
1 HTT aggregates have been shown to be taken up by 
endocytosis and directed to lysosomal compartment in 
both mitotic and nonmitotic neuroblastoma cells [64], 
although it is not known whether this process occurs 
in vivo.
MVBs and the endosome-lysosome system have been 
previously implicated in HD pathogenesis. HTT anti-
bodies have been shown to bind to MVBs in HD patient 
brains [66] and functional MVBs were required for the 
efficient clearance of HTT aggregates via autophagic 
degradation [15]. Transfection of clonal striatal rat cells 
with HTT constructs stimulated the endosomal–lyso-
somal pathway, endosomal tubulation and the number, 
size and morphological variability of autophagic vacuoles 
and lysosome-like bodies [29]. RAB5 has been reported 
to recruit HTT to early endosomes via huntingtin asso-
ciated protein 40 (HAP40) and mutant HTT results in 
altered endosome motility and endocytic activity [55]. 
In addition, inhibition of RAB5 enhanced polyQ toxicity 
in cell and fly models, potentially identifying a novel role 
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for RAB5 in the early stages of autophagosome formation 
[61]. Mutant HTT impairs vesicle formation from recy-
cling endosome by interfering with RAB11 activity [42], 
which is disrupted in a knockin mouse model of HD [41] 
and slows the recycling of the EAAC1 glutamate/cysteine 
transporter to the plasma membrane, leading to deficient 
glutathione synthesis and oxidative stress [43]. Our data 
are consistent with these reports in which total levels of 
RAB11 were not changed in HD [41].
Our data suggest that mutant HTT dysregulates exocy-
tosis in vivo, a novel mechanism through which mutant 
HTT disrupts the endolysosomal pathway (Fig.  9b). We 
found that the exosome proteins RAB27a and CD63 were 
both decreased by up to 30% in hippocampal lysates from 
zQ175 mice aged 6  months and R6/2 mice aged 8 and 
12  weeks (Fig.  8), indicating that the depletion of these 
proteins occurs throughout the entire disease course 
in these mouse models. CD63 is a tetraspanin that is 
enriched on the ILVs that are secreted as exosomes [59], 
and RAB27 functions in MVB docking at the plasma 
membrane [54]. These changes could reflect a shift in 
endolysosomal homeostasis away from exocytosis toward 
lysosome fusion and degradation, in response to the 
need to clear the chronically aggregating mutant HTT 
(Fig.  9b). In support of this, we detected an increase in 
cathepsin B in hippocampal lysates form 8- and 12-week-
old R6/2 mice (Fig.  8c-f ). Mutant HTT might induce a 
block in the pathway at the MVB / amphisome / autol-
ysosome stages, a hypothesis supported by the frequently 
observed phagophore-like structures that appear poised 
to engulf the recruitment organelles (Fig. 9b).
We have established a method to correlate fluorescence 
microscopy images with their underlying EM-resolved 
structures on the same brain sections from mouse mod-
els of HD. In the work presented here, the fluorescent sig-
nal resulted from the recruitment of labelled exon 1 HTT 
proteins. This allowed us to determine the ultrastructure 
of a subset of the puncta seen by antibody staining and 
confocal microscopy. We have now adapted CLEM for 
use with fluorescently labelled antibodies on tissue sec-
tions to determine whether other aggregated HTT-rich 
puncta might contain alternative HTT aggregated states, 
or more complex structures as have been discovered for 
Lewy bodies in Parkinson’s disease [38, 46, 71]. Causative 
and risk-associated mutations, for a broad spectrum of 
neurodegenerative diseases, have been identified in many 
genes involved in the endolysosomal and autophagic 
pathways [47]. Our demonstration that proteins impor-
tant for MVB-related exocytosis are considerably 
depleted throughout the disease course in vivo provides 
further evidence demonstrating that the endolysosomal 
pathway is dysregulated in HD and is likely to contribute 
to the pathogenic process.
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